Abstract
Iseki et al. [1] have shown that serum levels of albumin (Alb), creatinine (Cr) and BMI are significant predictors of death in haemodialyzed patients (HD pts).
In our study we decided to assess the relationship between the levels of Alb, Cr, BMI and substances which have a known metabolic effect on nutritional status in HD pts: endogenous erythropoietin (Epo), insulin-like growth factor-1 (IGF-I), leptin (Lep), parathormone (PTH), and testosterone. The study was conducted in 53 (28M, 25F) stable HD pts. Serum levels of endogenous Epo and PTH were estimated by CLIA; IGF-I, Lep, testosterone, sex hormone binding globulin were estimated by RIA. The multiple regression analysis was done between Alb, Cr, BMI and Epo, IGF-I, PTH and Lep for all HD pts together and free androgen index (FAI) for men and women separately. Correlations: the level of serum albumin did not correlate significantly with any of the measured substances. Serum creatinine level significantly correlated only with the level of IGF-I (p=0.02), BMI was significantly correlated with serum endogenous Epo (p<0.01), leptin (p=0.004) and FAI (p<0.005) both in men and women. We concluded that the higher concentrations of endogenous Epo, IGF-I and testosterone could be correlated with a better prognosis in HD patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Iseki, K., Kawazoe, W., Fukiyama, K.: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int., 44, 115 (1993).
Acchiardo, S. R., Moore, L. W., Latour, P. A.: Malnutrition as the main factor in morbidity and mortality of haemodialysis patients. Kidney Int., 24, S16 (1983).
Avram, M. M., Sreedhara, R., Mittman, N.: Long-term survival in end-stage renal disease. Dial. and Transplant., 27, 11 (1998).
Druml, W.: Malnutrition is bad, but how can one detect malnutrition. Nephrol. Dial. Transplant., 12, 2225 (1997).
Ikizler, T. A., Hakim, R. M.: Nutrition in end-stage renal disease. Kidney Int., 50, 343 (1996).
Guarnieri, G., Toigo, G., Fiotti, N., Ciocchi, B., Situlin, R., Giansante, C., Vasile, A., Carravo, M., Faccini, L., Biolo, G.: Mechanisms of malnutrition in uremia. Kidney Int., 52, S41 (1997).
Erslev, A. J., Besarab, A.: Erythropoietin in the pathogenesis and treatment of the anaemia of chronic renal failure. Kidney Int., 51, 622 (1997).
Kokot, F., Więcek, F., Schmidt-Gayk, H., Marcinkowski, W., Gilge, V., Heidland, A., Rudka, R., Trembecki, J.: Function of endocrine organs in hemodialyzed patients on long-term erythropoietin therapy. Artif. Organs, 19, 428 (1995).
Jacob, V., Carpentier, J. E., Salzano, S., Naylor, V., Wild, G., Brown, C. B., Nahas, A. M.: IGF-1, a marker of undernutrition in hemodialysis patients. Am. J. Clin. Nutr., 52, 39 (1990).
Sanaka, T., Shinobe, M., Audo, M., Hizuka, N., Kawaguchi, H., Nihei, H.: IGF-1 as an early indicator of malnutrition in patients with end-stage renal disease. Nephron, 67, 73 (1994).
Johansen, K. L., Mulligan, K., Tai, V., Schambelan, M.: Leptin, body composition and indices of malnutrition in patients on dialysis. JASN, 9, 1080 (1998).
Kokot, F., Więcek, F., Mesjasz, J., Adamezak, M., Spiechowicz, U.: Influence of long-term recombinant human erythropoietin therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. Nephrol. Dial. Transplant., 13, 1200 (1998).
Heimburger, O., Lönngvist, F., Daniclsson, A., Nordenström, J., Stenvinkel, P.: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J. Am. Soc. Nephrol., 8, 1423 (1997).
Bro, S., Olgaard, K.: PTH — one can teach an old hormone new tricks. Nephrol. Dial. Transpl., 12, 2222 (1997).
Massry, S. G.: Is parathormone a uremic toxin? Nephron, 19, 125 (1977).
Schaefer, F., Więcek, A., Ritz, E.: Endocrine Disorders. In: Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, New York, Tokyo (1998).
Ballal, S. H., Domoto, D. T., Polack, D. C., Marciulonis, P., Mortin, K. J.: Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am. J. Kidney Dis., 17, 29 (1991).
Teruel, J. L., Marcen, R., Navarro, J. F., Villafruela, J. J., Fernandez Lucas, M., Liano, F., Ortuno, J.: Evolution of serum erythropoietin after androgen administration to hemodialysis patients. A prospective study. Nephron, 70, 282 (1995).
Nanjee, M. N., Wheeler, M. J.: Plasma free testosterone — is an index sufficient? Ann. Clin. Biochem., 22, 387 (1985).
Fouque, D., Kopple, J. D.: Malnutrition and dialysis. In: Replacement Renal Function by Dialysis. Kluwer Academic Publishers. Dordrecht, Boston, London, (1996).
Jones, C. H., Newstead, C. G., Will, E. J., Smye, S. W., Davison, A. M.: Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure. Nephrol. Dial. Transplant., 12, 1406 (1997).
Majdan, M., Ksiąźek, A., Kotarski, J.: Relations between some prognostic parameters and serum insulin-like growth factor binding protein in HD pts. Ann. Univ. Maria Curie Sklodowska [Med.], 52, 37 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Majdan, M., Kotarski, J., Ksiaźek, A. et al. Relationship Between Some Prognostic Markers of HD Patients and Serum Erythropoietin, Insulin-like Growth Factor-1, Leptin, Parathormone and Testosterone. Int Urol Nephrol 31, 563–569 (1999). https://doi.org/10.1023/A:1007135916582
Issue Date:
DOI: https://doi.org/10.1023/A:1007135916582